|
Volumn 182, Issue 5, 2000, Pages 1350-1356
|
Cellular immunity to Human Immunodeficiency Virus type 1 (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ANTIGEN RECOGNITION;
ARTICLE;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSS REACTION;
CYTOTOXIC T LYMPHOCYTE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
UGANDA;
VIRUS STRAIN;
AIDS VACCINES;
EPITOPE MAPPING;
HIV-1;
HUMANS;
T-LYMPHOCYTES, CYTOTOXIC;
|
EID: 0033791350
PISSN: 00221899
EISSN: None
Source Type: Journal
DOI: 10.1086/315868 Document Type: Article |
Times cited : (65)
|
References (20)
|